학술논문
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group
Document Type
Article
Author
Herishanu, Y.; Perry, C.; Levi, S.; Benjamini, O.; Shaulov, A.; Goldschmidt, N.; Polliack, A.; Fineman, R.; Ringelstein, S.; Bašić-Kinda, S.; Aviv, A.; Wasik-Szczepanek, E.; Jaksic, O.; Zdrenghea, M.; Greenbaum, U.; Mandac, I.; Simkovic, M.; Morawska, M.; Spacek, M.; Nemets, A.; Bairey, O.; Itchaki, G.; Trentin, L.; Ruchlemer, R.; Laurenti, L.; Stanca Ciocan, O.; Doubek, M.; Shvidel, L.; Dali, N.; Mirás, F.; De Meûter, A.; Dimou, M.; Mauro, F.R.; Coscia, M.; Bumbea, H.; Szász, R.; Tadmor, T.; Gutwein, O.; Gentile, M.; Scarfò, L.; Ghia, P.; Tedeschi, A.; Sportoletti, P.; Gimeno Vázquez, E.; Marquet, J.; Assouline, S.; Papaioannou, M.; Braester, A.; Levato, L.; Gregor, M.; Rigolin, G.M.; Loscertales, J.; Medina Perez, A.; Nijziel, M.R.; Popov, V.M.; Collado, R.; Slavutsky, I.
Source
In: American Journal of Hematology . (American Journal of Hematology, 1 June 2020, 95(6):604-611)
Subject
Language
English
ISSN
10968652
03618609
03618609